Nano-vaccines combining customized in situ anti-PD-L1 depot for enhanced tumor immunotherapy-Reference-Cited by-同舟云学术

Nano-vaccines combining customized in situ anti-PD-L1 depot for enhanced tumor immunotherapy

Published:2023-09 Issue: Volume:53 Page:102693
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Chen Qian,Sun Mengjuan,Li Yanan,Huang Liping,Zu Chang,Kuang Xiaoqin,Zhao Jianing,Hao Mingyu,Ma Tingting,Li Chunjiayu,Tu Jiasheng,Sun Chunmeng,Du Yunai

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference24 articles.

1. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth;Baell;Nature,2018

2. Cancer immunotherapy comes of age and looks for maturity;Finck;Nat Commun,2020

3. Charting roadmaps towards novel and safe synergistic immunotherapy combinations;Sanmamed;Nat Cancer,2022

4. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade;Morad;Cell,2021

5. Combination cancer immunotherapy and new immunomodulatory targets;Mahoney;Nat Rev Drug Discov,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Intellectual Landscape of Nanovaccines: A Bibliometric Perspective on Scientific Progress and Future Directions;Cureus;2024-05-12

2. The quest for nanoparticle-powered vaccines in cancer immunotherapy;Journal of Nanobiotechnology;2024-02-14

3. Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy;Bioactive Materials;2024-01